An Intelligence Institution, Not a News Feed
Nysom Intelligence OS operates as a professional intelligence service, providing structured, decision-ready briefings to executives and compliance professionals navigating high-stakes regulatory environments.
Who We Are
Nysom Intelligence Group
Nysom Intelligence OS is operated by the Nysom Intelligence Group, a specialized regulatory intelligence firm founded by professionals with deep experience in FDA-regulated industries, compliance consulting, and executive advisory services.
How We Source & Verify
Primary Sources Only
We monitor official FDA channels, Federal Register notices, guidance documents, warning letters, and enforcement databases directly. No reliance on secondary news aggregators or unverified social media.
Materiality Filter
Not every FDA action warrants a brief. We apply a materiality threshold: Does this development require decision-makers to consider adjustments? If not, we don't publish noise.
Interpretation Layer
Raw regulatory text is translated into implications. We explain what changed, why it matters, and what considerations emerge—drawing on pattern recognition from historical precedents.
Citation Standards
Every brief includes verifiable source citations. Readers can trace our interpretation back to primary documents. Transparency is non-negotiable.
Our Leadership Team
Nysom Intelligence Group is led by professionals with direct experience in FDA-regulated environments, compliance operations, and executive advisory.
Founding Director
Regulatory Intelligence
15+ years FDA regulatory experience
Former compliance officer, top-10 pharma
Led regulatory strategy for 3 FDA submissions
Senior Analyst
Device & Digital Health
10+ years medical device regulatory
Managed 20+ 510(k) submissions
SaMD and AI/ML pathway expertise
Quality Intelligence Lead
CGMP & Enforcement
12+ years quality & compliance
Remediation lead for FDA warning letter
CDMO and contract manufacturing expert
35+
Combined Years Experience
50+
FDA Submissions Supported
200+
Warning Letters Analyzed
7
Industry Sectors Covered
Team member identities are protected for professional reasons. Credentials are verifiable upon request for enterprise subscribers.
Our Philosophy
The modern professional drowns in information but thirsts for intelligence. News feeds deliver volume; Nysom delivers clarity. We believe that high-stakes domains require a different approach—one that respects the time and judgment of decision-makers.
Each intelligence brief from Nysom is crafted to answer the question: "What does this mean for my decisions?" We do not simply report what happened. We interpret implications, identify patterns, and frame considerations—while always respecting the boundary between intelligence and advice.
"This brief interprets..." not "You should..."
Our commitment to professional boundaries
Our Principles
Continuous Vigilance
We maintain persistent surveillance of regulatory domains so our clients are never caught off-guard by material developments.
Interpretation Over Reporting
Raw information is abundant. Our value lies in interpretation—identifying what matters and why it matters now.
Decision-Ready Format
Every brief is structured to be actionable. Impact summaries, clear implications, and cited sources for verification.
Professional Boundaries
We provide intelligence, not advice. We inform decisions, we do not make them. This distinction is foundational.
Contact Us
Response Time
Within 24 business hours
For subscription inquiries, custom briefing requests, or partnership discussions.
Important Boundaries
Nysom Intelligence OS provides regulatory intelligence for decision-framing purposes. Our briefs interpret publicly available information and identify potential implications.
We do not provide: Legal advice, medical advice, financial recommendations, or definitive predictions of regulatory outcomes.
Subscribers should consult appropriate professional advisors for specific guidance on their situations. Our intelligence informs professional judgment; it does not replace it.
For complete details, see our Terms of Service, Privacy Policy, and Editorial Standards.